Ongoing accountability
Random selection maintains an external testing expectation after the original monitoring agreement has ended.
Continued recovery support
Continuum helps healthcare professionals continue the drug-testing component of an accountability plan after a formal monitoring program has ended.
Completion of a formal monitoring program is an important milestone, but it can also remove a familiar source of structure. A professional may continue treatment, peer support, recovery meetings, or other components of a personal recovery plan while no longer receiving random drug tests.
Continuum’s post-monitoring service is designed to provide that missing testing component. It offers continued random selection, documented participation, and practical home-collection options without requiring the full structure or intrusiveness of a traditional collection-site program.
Post-monitoring testing is not a substitute for treatment or other recovery supports. It is a focused service for professionals who want random testing to remain part of their long-term accountability plan.
Random selection maintains an external testing expectation after the original monitoring agreement has ended.
At-home collection reduces travel and avoids arranging a traditional collection-site appointment for each eligible test.
Testing activity and results provide a continuing record of participation in the selected plan.
The plan can be established around the desired level of support rather than automatically replicating a prior program.
The testing process is designed to fit around clinical schedules and reduce unnecessary public collection-site visits.
Professionals throughout the United States can participate through Continuum’s remote monitoring model.
The participant orders the assigned saliva or nail testing kits online, and the kits are delivered to the home in advance.
On a selected day, the participant receives a testing notification by text message and acknowledges it.
The assigned collection is completed through the required video-verification process within the same-day testing window.
The completed test is secured in the supplied prepaid shipping envelope according to the provided instructions.
The sealed package is taken to an authorized FedEx drop-off location for delivery to the laboratory.
Post-monitoring testing may be chosen by the professional, recommended by a treatment provider, included in an employment arrangement, or used to maintain a personally meaningful level of accountability after formal program completion.
Continuum will explain the testing process and establish the plan before participation begins. The service remains independent from any prior program unless a separate authorized arrangement is established.
Continuum’s post-monitoring service provides random drug testing and related accountability. It does not automatically continue the legal authority, advocacy, worksite monitoring, treatment oversight, or licensing-board relationship of a prior state or professional program.
Monitoring needs vary. Continuum will explain the applicable process before participation begins.
It is continued random drug testing after a formal state, professional, employer, or treatment-related monitoring program has ended. It provides an ongoing accountability component without recreating every part of a full regulatory program.
No. The service is designed for people leaving formal monitoring, but it may also be appropriate when another structured program has ended or when a professional voluntarily wants continued random testing.
The participant receives a text message on the selected testing day, acknowledges the notification, and completes the assigned test by the end of that day.
Eligible saliva and nail tests are completed from home through the assigned video-verification process. The specimen is then sealed in the prepaid shipping envelope and taken to an authorized FedEx drop-off location.
The frequency can be established to match the intended level of accountability. Any change should be discussed and documented as part of the participant’s plan.
Call, text, email, or send a brief inquiry. Please do not include diagnoses, test results, Social Security numbers, or other sensitive medical information.